Through national frameworks, open-source innovation and homegrown models such as Falcon, Abu Dhabi is shaping a distinctive approach to AI governance and deployment.
Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback